Alkermes Plc (ALKS)

Jan 17, 2025

Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 14.1% - MarketBeat

Jan 17, 2025

Jan 16, 2025

Benign Growth For Alkermes plc (NASDAQ:ALKS) Underpins Its Share Price - Simply Wall St

Jan 16, 2025

Jan 13, 2025

(ALKS) Proactive Strategies - Stock Traders Daily

Jan 13, 2025

Jan 13, 2025

Alkermes plc (NASDAQ:ALKS) Holdings Trimmed by JPMorgan Chase & Co. - MarketBeat

Jan 13, 2025

Jan 09, 2025

Zacks Research Reduces Earnings Estimates for Alkermes - MarketBeat

Jan 09, 2025

Jan 08, 2025

What is Zacks Research's Forecast for Alkermes Q2 Earnings? - MarketBeat

Jan 08, 2025

Jan 05, 2025

Alkermes plc (NASDAQ:ALKS) Receives $36.00 Average PT from Brokerages - MarketBeat

Jan 05, 2025

Jan 02, 2025

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com

Jan 02, 2025

Jan 02, 2025

Alkermes CEO to Present Corporate Strategy at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 02, 2025

Dec 31, 2024

Alkermes to Report Third Quarter Financial Results on October 24, 2024 - Quantisnow

Dec 31, 2024

Dec 31, 2024

Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes plc (NASDAQ:ALKS)? - Yahoo Finance

Dec 31, 2024

Dec 30, 2024

Alkermes plc (NASDAQ:ALKS) Sees Large Decrease in Short Interest - MarketBeat

Dec 30, 2024

Dec 26, 2024

Principal Financial Group Inc. Has $24.57 Million Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 26, 2024

Dec 23, 2024

(ALKS) On The My Stocks Page - Stock Traders Daily

Dec 23, 2024

Dec 23, 2024

Alkermes plc (NASDAQ:ALKS) Stake Boosted by Sanctuary Advisors LLC - MarketBeat

Dec 23, 2024

Dec 20, 2024

Expansion Therapeutics Names Elliot Ehrich, MD, Chief Medical Officer - Marketscreener.com

Dec 20, 2024

Dec 20, 2024

Alkermes pays off and terminates major credit agreement By Investing.com - Investing.com Canada

Dec 20, 2024

Dec 20, 2024

2025 will be a big year for Mural Oncology's drugs in development - The Business Journals

Dec 20, 2024

Dec 20, 2024

Alkermes pays off and terminates major credit agreement - Investing.com

Dec 20, 2024

Dec 20, 2024

Alkermes Prepares for New Flexibility Post Credit Termination - TipRanks

Dec 20, 2024

Dec 20, 2024

Tidal Investments LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 20, 2024

Dec 19, 2024

Geode Capital Management LLC Sells 60,037 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 19, 2024

Dec 17, 2024

We Think Alkermes (NASDAQ:ALKS) Can Stay On Top Of Its Debt - Simply Wall St

Dec 17, 2024

Dec 16, 2024

Wilmington Savings Fund Society FSB Invests $582,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 16, 2024

Dec 16, 2024

Barclays PLC Boosts Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 16, 2024

Dec 14, 2024

Alkermes To Take Part In The Fourth Annual Evercore ISI Healthconx Conference - Environmental Expert

Dec 14, 2024

Dec 13, 2024

Opioid Use Disorder Market: Share, Key Trends, Growth Drivers, - openPR

Dec 13, 2024

Dec 12, 2024

When (ALKS) Moves Investors should Listen - Stock Traders Daily

Dec 12, 2024

Dec 12, 2024

Fmr LLC Has $9.71 Million Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 12, 2024

Dec 11, 2024

State Street Corp Lowers Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 11, 2024

Dec 11, 2024

Alkermes plc (NASDAQ:ALKS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 11, 2024

Dec 10, 2024

Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million By Investing.com - Investing.com South Africa

Dec 10, 2024

Dec 10, 2024

Frazier Life Sciences Management L.P. Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 10, 2024

Dec 10, 2024

Alkermes director Cato Laurencin sells $85,708 in stock - Investing.com India

Dec 10, 2024

Dec 09, 2024

Alkermes director Cato Laurencin sells $85,708 in stock By Investing.com - Investing.com Canada

Dec 09, 2024

Dec 09, 2024

Alkermes' EVP Craig Hopkinson sells shares worth $1.96 million - Investing.com

Dec 09, 2024

Dec 08, 2024

Wellington Management Group LLP Sells 1,696,507 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 08, 2024

Dec 08, 2024

Alkermes plc (NASDAQ:ALKS) Stake Lifted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat

Dec 08, 2024

Dec 06, 2024

Insider Sell: Craig Hopkinson Sells 9,221 Shares of Alkermes PLC (ALKS) - GuruFocus.com

Dec 06, 2024

Dec 05, 2024

Alkermes' chief medical officer sells $290,461 in stock - Investing.com India

Dec 05, 2024

Dec 05, 2024

Alkermes' chief medical officer sells $290,461 in stock By Investing.com - Investing.com UK

Dec 05, 2024

Dec 05, 2024

Insider Sell: Craig Hopkinson Sells 14,349 Shares of Alkermes PL - GuruFocus.com

Dec 05, 2024

Dec 05, 2024

RTW Investments LP Sells 402,955 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 05, 2024

Dec 05, 2024

BNP Paribas Financial Markets Buys 63,939 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Alkermes EVP and chief medical officer sells shares worth $441,550 By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

Alkermes EVP and chief medical officer sells shares worth $441,550 - Investing.com

Dec 04, 2024

Dec 04, 2024

Alkermes PLC (ALKS) Shares Up 4.58% on Dec 4 - GuruFocus.com

Dec 04, 2024